SEC Form 4 · accession 0001209191-17-060589
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Nov 10, 2017
Accepted (ET)
Nov 14, 2017 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2017 | M | 1,493 | $2.0864 | A | 28,798 | D | |
| Common Stock | Nov 10, 2017 | M | 578 | $5.5004 | A | 29,376 | D | |
| Common Stock | Nov 10, 2017 | M | 7,829 | $24.47 | A | 37,205 | D | |
| Common StockF2 | Nov 10, 2017 | S | 2,100 | $148.7548 | D | 35,105 | D | |
| Common StockF3 | Nov 10, 2017 | S | 6,600 | $149.7363 | D | 28,505 | D | |
| Common StockF4 | Nov 10, 2017 | S | 1,200 | $150.1833 | D | 27,305 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $2.0864 | Nov 10, 2017 | M | 1,493 | D | — | Jul 13, 2021 | Common Stock | 1,493 | 8,743 | D |
| Stock Option (right to buy)F6 | $5.5004 | Nov 10, 2017 | M | 578 | D | — | Jan 16, 2023 | Common Stock | 578 | 27,007 | D |
| Stock Option (right to buy)F7 | $24.47 | Nov 10, 2017 | M | 7,829 | D | — | Mar 3, 2024 | Common Stock | 7,829 | 42,171 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2016.
- F2The range of prices for the transaction reported on this line was $148.1000 to $149.0500. The average weighted price was $148.7548. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $149.1000 to $150.0750. The average weighted price was $149.7363. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $150.1000 to $150.2750. The average weighted price was $150.1833. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.
- F6This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of April 1, 2013. The shares underlying these options vested as follows: 25% vested on April 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F7This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.